Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 87


Dampening enthusiasm for circulating microRNA in breast cancer.

Leidner RS, Li L, Thompson CL.

PLoS One. 2013;8(3):e57841. doi: 10.1371/journal.pone.0057841. Epub 2013 Mar 5.


Circulating micro-RNAs as potential blood-based markers for early stage breast cancer detection.

Schrauder MG, Strick R, Schulz-Wendtland R, Strissel PL, Kahmann L, Loehberg CR, Lux MP, Jud SM, Hartmann A, Hein A, Bayer CM, Bani MR, Richter S, Adamietz BR, Wenkel E, Rauh C, Beckmann MW, Fasching PA.

PLoS One. 2012;7(1):e29770. doi: 10.1371/journal.pone.0029770. Epub 2012 Jan 5.


Novel circulating microRNA signature as a potential non-invasive multi-marker test in ER-positive early-stage breast cancer: a case control study.

Kodahl AR, Lyng MB, Binder H, Cold S, Gravgaard K, Knoop AS, Ditzel HJ.

Mol Oncol. 2014 Jul;8(5):874-83. doi: 10.1016/j.molonc.2014.03.002. Epub 2014 Mar 16.


A circulating miRNA signature as a diagnostic biomarker for non-invasive early detection of breast cancer.

Zhang L, Xu Y, Jin X, Wang Z, Wu Y, Zhao D, Chen G, Li D, Wang X, Cao H, Xie Y, Liang Z.

Breast Cancer Res Treat. 2015 Nov;154(2):423-34. doi: 10.1007/s10549-015-3591-0. Epub 2015 Oct 17.


Analysis of serum genome-wide microRNAs for breast cancer detection.

Wu Q, Wang C, Lu Z, Guo L, Ge Q.

Clin Chim Acta. 2012 Jul 11;413(13-14):1058-65. doi: 10.1016/j.cca.2012.02.016. Epub 2012 Feb 23.


Tumor microRNA expression profiling identifies circulating microRNAs for early breast cancer detection.

Matamala N, Vargas MT, González-Cámpora R, Miñambres R, Arias JI, Menéndez P, Andrés-León E, Gómez-López G, Yanowsky K, Calvete-Candenas J, Inglada-Pérez L, Martínez-Delgado B, Benítez J.

Clin Chem. 2015 Aug;61(8):1098-106. doi: 10.1373/clinchem.2015.238691. Epub 2015 Jun 8.


Identification of circulating microRNA signatures for breast cancer detection.

Chan M, Liaw CS, Ji SM, Tan HH, Wong CY, Thike AA, Tan PH, Ho GH, Lee AS.

Clin Cancer Res. 2013 Aug 15;19(16):4477-87. doi: 10.1158/1078-0432.CCR-12-3401. Epub 2013 Jun 24.


Expression profiling of cancerous and normal breast tissues identifies microRNAs that are differentially expressed in serum from patients with (metastatic) breast cancer and healthy volunteers.

van Schooneveld E, Wouters MC, Van der Auwera I, Peeters DJ, Wildiers H, Van Dam PA, Vergote I, Vermeulen PB, Dirix LY, Van Laere SJ.

Breast Cancer Res. 2012 Feb 21;14(1):R34.


Next-generation sequencing of microRNAs for breast cancer detection.

Wu Q, Lu Z, Li H, Lu J, Guo L, Ge Q.

J Biomed Biotechnol. 2011;2011:597145. doi: 10.1155/2011/597145. Epub 2011 May 26.


Circulating microRNAs as specific biomarkers for breast cancer detection.

Ng EK, Li R, Shin VY, Jin HC, Leung CP, Ma ES, Pang R, Chua D, Chu KM, Law WL, Law SY, Poon RT, Kwong A.

PLoS One. 2013;8(1):e53141. doi: 10.1371/journal.pone.0053141. Epub 2013 Jan 3.


Identification and validation of oncologic miRNA biomarkers for luminal A-like breast cancer.

McDermott AM, Miller N, Wall D, Martyn LM, Ball G, Sweeney KJ, Kerin MJ.

PLoS One. 2014 Jan 31;9(1):e87032. doi: 10.1371/journal.pone.0087032. eCollection 2014.


Alterations in circulating miRNA levels following early-stage estrogen receptor-positive breast cancer resection in post-menopausal women.

Kodahl AR, Zeuthen P, Binder H, Knoop AS, Ditzel HJ.

PLoS One. 2014 Jul 8;9(7):e101950. doi: 10.1371/journal.pone.0101950. eCollection 2014.


De novo sequencing of circulating miRNAs identifies novel markers predicting clinical outcome of locally advanced breast cancer.

Wu X, Somlo G, Yu Y, Palomares MR, Li AX, Zhou W, Chow A, Yen Y, Rossi JJ, Gao H, Wang J, Yuan YC, Frankel P, Li S, Ashing-Giwa KT, Sun G, Wang Y, Smith R, Robinson K, Ren X, Wang SE.

J Transl Med. 2012 Mar 8;10:42. doi: 10.1186/1479-5876-10-42.


Serum microRNA expression as an early marker for breast cancer risk in prospectively collected samples from the Sister Study cohort.

Godfrey AC, Xu Z, Weinberg CR, Getts RC, Wade PA, DeRoo LA, Sandler DP, Taylor JA.

Breast Cancer Res. 2013 May 24;15(3):R42. doi: 10.1186/bcr3428.


A pilot study of circulating miRNAs as potential biomarkers of early stage breast cancer.

Zhao H, Shen J, Medico L, Wang D, Ambrosone CB, Liu S.

PLoS One. 2010 Oct 29;5(10):e13735. doi: 10.1371/journal.pone.0013735.


Impact of tumour epithelial subtype on circulating microRNAs in breast cancer patients.

Waters PS, Dwyer RM, Brougham C, Glynn CL, Wall D, Hyland P, Duignan M, McLoughlin M, Newell J, Kerin MJ.

PLoS One. 2014 Mar 13;9(3):e90605. doi: 10.1371/journal.pone.0090605. eCollection 2014.


Circulating miRNAs revealed as surrogate molecular signatures for the early detection of breast cancer.

Mishra S, Srivastava AK, Suman S, Kumar V, Shukla Y.

Cancer Lett. 2015 Dec 1;369(1):67-75. doi: 10.1016/j.canlet.2015.07.045. Epub 2015 Aug 11.


Overexpression of circulating miRNA-21 and miRNA-146a in plasma samples of breast cancer patients.

Kumar S, Keerthana R, Pazhanimuthu A, Perumal P.

Indian J Biochem Biophys. 2013 Jun;50(3):210-4.


The expression of microRNA-375 in plasma and tissue is matched in human colorectal cancer.

Xu L, Li M, Wang M, Yan D, Feng G, An G.

BMC Cancer. 2014 Sep 25;14:714. doi: 10.1186/1471-2407-14-714.


Circulating microRNA-92a and microRNA-21 as novel minimally invasive biomarkers for primary breast cancer.

Si H, Sun X, Chen Y, Cao Y, Chen S, Wang H, Hu C.

J Cancer Res Clin Oncol. 2013 Feb;139(2):223-9. doi: 10.1007/s00432-012-1315-y. Epub 2012 Sep 30.

Supplemental Content

Support Center